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(5-20 mM) were added to the cell cultures before and during the OGD/R
phases to investigate the underlying mechanism.
RESULTS Our data showed that OGD/R decreased cell viability,
increased lactate dehydrogenase leakage, reactive oxygen species and
malondialdehydeproduction inH9c2 cells, all ofwhichwere signiﬁcantly
reversed by propofol. Moreover, we found that propofol increased both
the activities and protein expressions of superoxide dismutase and
catalase. In addition, propofol increased FoxO1 expression in a dose-
dependent manner and inhibited p-AMPK formation signiﬁcantly.
CONCLUSIONS These results indicate that the propofol might exert its
antioxidative effect through FoxO1 in H9c2 cells, and it has a potential
therapeutic effect on cardiac disorders involved in oxidative stress.
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Echocardiography-guided percutaneous laser ablation of canine
ventricular septum
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OBJECTIVES Currently surgical myectomy and ethanol ablation are two
established interventions for relieving the left ventricular outﬂow
obstruction in hypertrophic cardiomyopathy (HCM) patients. The limi-
tations in safety and efﬁcacy in these interventions call for minimally
invasive, potentially safer andmore efﬁcacious approach. The aim of this
study is to validate the feasibility of echocardiography-guided percuta-
neous per-ventricular laser ablation of the canine ventricular septum.
METHODS Six domestic dogs were chosen for the study. Laser (Nd:
YAG, 800-1064 nm-wavelength, 300mm-diameter ﬁber, Echo Laser
X4, Elesta S.R.L., Italy) was used. The laser passed through a needle
(21G, PTC, ECOCHIBA, Italy) that inserted from the right ventricle into
the targeted septum under the guidance of the echocardiography via a
percutaneous route. Laser ablation was performed as follows: 1 W
laser for 3 and 5 min at 180 and 300 J, respectively. Echocardiography,
serology examination and pathology were performed to assess the
results of laser ablation.
RESULTS There was no death or major complication, i.e. tamponade,
pericardial effusion or ventricular ﬁbrillation. The real-time echocar-
diography monitor of M-mode, 2D (LVEF), PW Doppler and TDI pre-
sented no signiﬁcant variation before and after the laser ablation.
Contrast echocardiography conﬁrmed the perfusion defects in the
ablated septal regions. The laser ablated areas were well demarcated
on pathology examination and the diameters of the ablated region
were (mm) 4.42  0.57 and 5.28  0.83 for 3- and 5-minute ablation,
respectively. Pre- and post-ablation cardiac enzymes (IU/L) were: AST:
39.17  11.23 vs 183  101.07 (p¼0.02), LDH: 71  33.89 vs 253.33 
179.63 (p¼0.07), CK: 468.17 192.42 vs 2775.17  1309.35 (p¼0.007),
and CK-MB: 174.33  113.34 vs 897.17  486.84 (p¼0.03). Microscop-
ically, the ablated myocardium showed contracted coagulative
changes. Nuclei disappeared and a zone of vacuoles was formed with
red blood cells inﬁltrating into the widened intercellular space.
CONCLUSIONS Our research showed that percutaneous laser ablation
of the septum is feasible, potentially safe and efﬁcacious and may
become a viable alternative solution to septum ablation.
GW26-e2407
Protective Effects of Dihydromyricetin and Myricetin against Myocardial
Ischemia/Reperfusion Injury In Vivo and In Vitro
Yong Ye,1 Xianhong OU,2 Qiujie Huang,3 Huagang Liu,1
Yonghong Liang,1 Yefei Yuan,4 Yunfei Song,5 Xiaorong Zeng2
1College of pharmacy, Guangxi Medical University, Nanning 530021,
Guangxi, China; 2The Key Laboratory of Medical Electrophysiology,
Ministry of Education of China, and the Institute of Cardiovascular
Research, Luzhou Medical College; 3College of pharmacy, Guangxi
Traditional Chinese Medical University, Guangxi Nanning 530001,
China; 4College of pharmacy, Luzhou Medical College, Luzhou 646000,
Sichuan, China; 5Postdoctoral R&D Workstations, Guilin Layn Natural
Ingredients Corp, Guilin 541100, China
OBJECTIVES The aims of this study were to determine whether Myr
or DMY exert any cardioprotective effect against I/R injury and
investigate the responsible underlying mechanisms.
METHODS The study utilized an in vitro rat cardiomyocyteH9C2model
of hypoxia/reoxygenation (H/R) injury and an in vivo rat model of MI/R
injury. H/R injury was determined by Cell Counting Kit-8 (CCK-8) assay
and lactate dehydrogenase (LDH) leakage assay. In the in vivoexperiment, histopathology staining was examined. Additionally, car-
diac injury markers maleic dialdehyde (MDA), superoxide dismutase
(SOD), glutathione reductase (GSH), myeloperoxidase (MPO), nitric-
oxide synthase (NOS), Ca2þ-Mg2þ-ATPase and Naþ-Kþ-ATPase were
detected. TUNEL assay and caspases activation assays were used to
investigate apoptosis. To assess levels of apoptotic regulators, immu-
nohistochemical staining and real-time PCR were employed.
RESULTS Both Myr and DMY have no cytotoxic effect at the concen-
trations of 0.5-80 mMMyr or 10-200 mMDMY for 24 hours in H9C2 cells.
after being subject to H/R, cellular viability was signiﬁcantly reduced in
the H/R group (P < 0.01 compared to control), and LDH leakage was
highly increased compared to control (P < 0.01). DMY or Myr post-
conditioning signiﬁcantly increased cell viability compared with the H/
R group. DMY (25, 50 and 100 mM) or Myr (20 and 50 mM) markedly
reducedH/R-induced cell death and decreased LDH leakage (P<0.05 or
P < 0.01). These results indicate that DMY and Myr signiﬁcantly pre-
served cellular viability post-H/R injury in a dose-dependent manner.
Both DMY andMyr protectedmyocardium against I/R (or H/R) injury by
increasing NOS, SOD, GSH and ATPases activity, decreasing MDA con-
tent and MPO activity at different degrees and attenuating histopa-
thology injury. Meanwhile, DMY and Myr inhibited the cardiomyocyte
apoptosis. The level of Bcl-2 protein and mRNA were restored to the
normal level by DMY or Myr pharmacological postconditioning. In
contrast, the Bax protein level andmRNA level were markedly reduced
by DMY and Myr pharmacological postconditioning.
CONCLUSIONS DMY andMyr pharmacological postconditioning could
protect againstmyocardial I/R injury in both in vivo and in vitromodels,
which are related to apoptosis pathway and antioxidant activity.
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OBJECTIVES To observe the effect of high glucose on the protein
expression of calreticulin (CRT) and its association with cell apoptosis
and mitochondrial dysfunction in the cardiomyocytes.
METHODS AC-16 cardiomyocytes were randomly divided into normal
glucose group, high glucose group, high glucoseþ CRT siRNA and
isotonic control group. The cell apoptotic rate, reactive oxygen species
(ROS), mitochondrial membrane potential level, respiratory enzyme
activities, and protein expression of CRT were observed.
RESULTS Compared with the cardiomyocytes in normal glucose
group, the apoptotic rate of cardiomyocytes and ROS production
increased in high glucose groups, accompanying with the decreases in
the mitochondrial membrane potential level and enzyme activities of
the respiratory chain. The protein expression of CRT was signiﬁcantly
increased in high glucose group. However, compared with high
glucose group, high glucoseþ CRT siRNA decreased the expression of
CRT and attenuated the damage of mitochondrion, but CRT siRNA did
not reduce the ROS level in cardiomyocytes.
CONCLUSIONS High glucose brought about CRT over-expression to
induce mitochondrial injury, which may be a reason of increasing
myocardial apoptosis.
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OBJECTIVES L-carnitine is indispensable for energy metabolism and
mitochondrial function in the myocardium. Although carnitine
C86 J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 6 , N O . 1 6 , S U P P L S , 2 0 1 5deﬁciency have been implicated in development of left ventricular
failure, little is known about the role of L-carnitine in the right ven-
tricular failure in pulmonary arterial hypertension.
METHODS Experimental pulmonary hypertension develops in male
Sprague-Dawley rats subjected to a single subcutaneous injection of
monocrotaline (60 mg kg-1, MCT group). Compared with the vehicle
group, by day 21, MCT group developed higher right ventricular
systolic pressure (345 mmHg versus 194 mmHg; P<0.001)
and right ventricular hypertrophy (0.510.13 versus 0.280.05;
P<0.001). In MCT group, L-carnitine levels were signiﬁcantly
decreased in both the right ventricular myocardium (15947 nmol/g
vs 43576 nmol/g, P<0.05) and plasma (73 umol/l vs 1610 umol/
l, P<0.05), indicating L-carnitine deﬁciency was associated with the
right ventricular failure. To evaluate whether supplementation with
L-carnitine could attenuate right ventricular failure, we treat the
rats received monocrotaline with either L-carnitine (500mg kg-1
day-1, L-carnitine MCT group) or saline (saline MCT group) for
14 days.
RESULTS In comparison with saline MCT group, the mean pulmonary
arterial pressure and the right ventricular systolic pressure decreased
by 34% (P¼0.04) and 25% (P¼0.01) in the L-carnitine MCT group,
respectively. The right ventricular hypertrophy index and right ven-
tricular free wall thickness decreased by 25% (P¼0.02) and 14%
(P¼0.03) in the L-carnitine MCT group, respectively. Furthermore, the
myocardial PET/ CT demonstrated that SUVRV / LV of L-carnitine MCT
group reduced by 15% when compared with saline MCT group
(P<0.05).
CONCLUSIONS The L-carnitine deﬁciency may aggravate develop-
ment of pulmonary hypertension. Supplementation with L-carnitine
could improve pulmonary arterial hypertension by reversing energy
metabolism dysfunction of right ventricular failure.GW26-e1573
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OBJECTIVES Growing evidence has shown that apelin/APJ system
functions as a critical mediator of cardiac development as well as
cardiovascular function. Here we investigated the role of apelin in the
cardiomyogenic differentiation of mesenchymal stem cells derived
from Wharton’s jelly-derived mesenchymal stem cells (WJ-MSCs) and
undescribed functional link between MAPK/ERK signaling cascade
and apelin/APJ axis in vitro.
METHODS We used RNA interference methodology and gene trans-
fection technique to regulate the expression of apelin in WJ-MSCs,
which were divided into four groups: (A) WJ-MSCs; (B) apelin-silenced
WJ-MSCs; (C) apelin-regained WJ-MSCs and the control group. All
groups were treated with an effective cardiac differentiation protocol
including 5-azacytidine and bFGF, except the control group. Cells
were analyzed by real-time RT-PCR, Western blot, Immunoﬂuores-
cence and Calcium ﬂux assay. MEK1/2 inhibitor PD0325901 and MEK5
inhibitor BIX02189 were used to regulated ERK1/2 and ERK5 in apelin-
silenced WJ-MSCs with/without supplementary apelin-13 during
Cardiomyogenic Differentiation.
RESULTS Four weeks after induction, cells in group A and C assumed
a stick-like morphology and myotube-like structures except apelin-
silenced cells and the control group. The silencing of apelin decreased
the expressions of several critical cardiac progenitor transcription
factors (Mesp1, Mef2c, NKX2.5) and cardiac phenotypes (cardiac a-
actin, b-MHC, cTnT and connexin-43). Meanwhile, endogenous
compensation of apelin contributed to differentiating into cells with
characteristics of cardiomyocytes in vitro. Remarkably, our experi-
ment indicated that apelin up-regulated cardiac speciﬁc genes in
Wharton’s jelly-derived mesenchymal stem cells via activating ERK1/2
and ERK5.
CONCLUSIONS Our study indicated that apelin was essential for
cardiomyogenic differentiation of WJ-MSCs via activating MEK1/2-
ERK1/2 and MEK5-ERK5, which were involved in MAPK signaling
pathway. Down-regulation of apelin in WJ-MSCs decreases the
expression of several critical cardiac progenitor transcription factors
and cardiac phenotypes.GW26-e2239
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OBJECTIVES Liqihuoxue pills (LQHX) is a compound Miao medicine
in China used for treatment of cardiovascular diseases, and can
decrease acute myocardial infarct and refusion injury in cat and rat.
This study was to investigate whether LQHX ameliorates atrial ﬁbril-
lation by prevention atrial ﬁbrosis in the isoproterenol- induced
myocardial infarct in rats. his study was to investigate whether LQHX
ameliorates atrial ﬁbrillation by prevention atrial ﬁbrosis in the
isoproterenol- induced myocardial infarct in rats.
METHODS Myocardial infarct (MI) rat model was induced by subcutane-
ous injection of 120mg/kg/d isoproterenol for 2 days.We studied a normal
control group and 4 groups of rats undergoing isoproterenol-inducedMI 1
week prior to treatment: isoproterenol (ISO) group, and ISO combined
with LQHX (ISOþLQHX) group. The three ISOþLQHX groups were
administered LQHX (187.5 mg/Kg, 75 mg/Kg, 37.5mg/Kg respectively) by
gavage for 4weeks after 7d for ISO treatment. After treatment for 4weeks,
cardiac function were measured by echocardiography and the histopath-
ological changes of cardiac tissue was observed via Masson’s staining. AF
inducibility and duration were detected by transesophageal programmed
electrical stimulation AF inducing technology. The atrial conduction ve-
locity was detected by multi-electrodes arrays measurements. The
expression of typeI and III collagen and the changes of transforming
growth factor b1 (TGF-b1) in left atrial were detected by western blot.
RESULTS LQHX (at the dose of 37.5 mg/Kg) signiﬁcantly improved left
systolic functions, resulting in improved LV ejection fraction
(64.64.42% vs 57.95.66%; P<0.05), LV internal dimension in systole
(4.740.51 mm vs 5.730.48 mm; P <0.01). LQHX-treated rats had
lower rates of AF inducibility (70%, 56%, 50% inLQHXgroups vs. 90% in
ISO group), and shorter AF duration.Masson’s trichrome staining in ISO
treated group reveals increased left atrial ﬁbrosis (63.45.8%), while
treatment with LQHX resulted in reversal of atrial ﬁbrosis, and in the
lower dose of LQHX group (37.5 mg/Kg) could decreased the left atrial
ﬁbrosis areas to (15.32.4)%. LQHX (at the dose of 75 mg/Kg and 37.5
mg/Kg) also obviously reduced the expression of type I and III collagen
in left atrium and markedly inhibited TGF-b1 protein expression.
CONCLUSIONS LQHX pills reduced the AF inducibility rate and
duration after ISO induced myocardial infarct by inhibiting left atrial
ﬁbrosis, and associate with inhibition typeIand III collagen and TGF-
b1 protein expression in left atrium of rat heart. It obviously suggests
that LQHX could be an effective Chinese drug for the prevention atrial
ﬁbrillation induced by post-MI myocardial remodeling.
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OBJECTIVES The aim of our study was to investigate the roles of
renal sympathetic nerve stimulation (RSS) on atrial ﬁbrillation (AF)
and cardiac autonomic nervous activity.
METHODS RSS was performed using electrical stimulation on the left
renal artery at the 30 volts for 3 hours. Twenty-eight dogs were
randomly assigned to the proximal renal sympathetic stimulation
(RSS) group (P-RSS, N¼7), middle RSS group (M-RSS, N¼7), distal RSS
group (D-RSS, N¼7), and the control group ( sham RSS, N¼7). Effective
refractory period (ERP) and the window of vulnerability (WOV) were
measured. SLGP and LSG function were determined. Neural activities
were recorded from the SLGP and LSG. C-fos and nerve growth factor
(NGF) protein expressing in the SLGP and LSG were examined. Serum
inﬂammatory cytokines were assayed.
RESULTS
(1) Only P-RSS caused pronounced blood pressure rises, induced a sig-
niﬁcant decrease in ERP, and generated a marked increase in WOV
and ERP Dispersion (all P < 0.05).
(2) P-RSS signiﬁcantly facilitated SLGP and LSG function.
(3) The frequency and amplitude of the neural activity in the SLGP and
LSG were markedly increased by P-RSS.
